Latest filing published 13 May 2025 for Integra Lifesciences Holdings CORP. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Barbara B. Hill across 2 companies, led by Integra Lifesciences Holdings Corp and St Jude Medical Inc. The record holds 7 filings, for trades running from 3 February 2016 to 9 May 2025.
Every open-market trade on record is a purchase: 1 purchase worth €917k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 1 option exercise.
The record was last updated on 13 May 2025 with a share grant in Integra Lifesciences Holdings Corp. The last insider purchase was made public on 22 May 2024, 879 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations